Polyplus-transfection SA, which specializes in the development of solutions for cellular and
molecular biology research
, announced today that Généthon, a not-for-profit biotherapy laboratory run by the French
Muscular Dystrophy
Association (AFM – Association Française contre les Myopathies) and which is financed by donations raised through the annual Téléthon, has selected Polyplus-transfection’s jetPEI transfection reagent for the production of its viral vectors. The financial terms of the deal were not disclosed.
